Publications scientifiques

2252 PUBLICATIONS

ANNÉE

JOURNAL

PREMIER AUTEUR

TITRE

ANNÉE2025

JOURNALTranslational oncology

PREMIER AUTEURJean C

TITRECurrents status of radiotracers for breast cancer imaging in PET.

ANNÉE2025

JOURNALFuture oncology (London, England)

PREMIER AUTEURBellio H

TITREFOLFIRINOX-3 plus bevacizumab (bFOLFIRINOX3) in chemo-refractory metastatic colorectal cancer: a multicenter phase II trial.

ANNÉE2025

JOURNALEuropean journal of clinical nutrition

PREMIER AUTEURPerrier M

TITREImpact of low muscle mass and myosteatosis on treatment toxicity and survival outcomes in non-resectable pancreatic cancer patients treated with chemoradiotherapy.

ANNÉE2025

JOURNALTranslational oncology

PREMIER AUTEURBetz M

TITREDecoding mutational signatures in breast cancer: Insights from a multi-cohort study.

ANNÉE2025

JOURNALClinical and experimental dermatology

PREMIER AUTEURHennemann A

TITREMalignant melanoma arising in a sebaceous naevus leading to the discovery of a pathogenic germline MUTYH mutation: a case report.

ANNÉE2025

JOURNALNanoscale

PREMIER AUTEURRamírez MLA

TITRESpacer engineering in nanoparticle-peptide conjugates boosts targeting specificity for tumor-associated antigens.

ANNÉE2025

JOURNALSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

PREMIER AUTEURVercueil C

TITREReal-world outcomes of metastatic cancer patients hospitalized at initial diagnosis: ONIRIS, a national study.

ANNÉE2025

JOURNALJHEP reports : innovation in hepatology

PREMIER AUTEURCrouchet E

TITREA patient-derived HCC spheroid system to model the tumor microenvironment and treatment response.

ANNÉE2025

JOURNALAnnals of surgical oncology

PREMIER AUTEURAddeo P

TITREASO Author Reflections: Complete Pathological Response after Neoadjuvant Treatment for Pancreatic Ductal Adenocarcinomas-Curative Surgery in Cured Patients?

ANNÉE2025

JOURNALNPJ breast cancer

PREMIER AUTEURLadoire S

TITREPrevalence, clinicopathologic features and long-term overall survival of early breast cancer patients eligible for adjuvant abemaciclib and/or ribociclib.

Retrouvez aussi

Unités de recherche, établissements

Projets de recherche

Publications scientifiques